Evidence map›Paper›PMID 40064819›Full record

ArticleJournal of general internal medicine2025

Subjective Cognitive Decline in COPD - A Cross-Sectional Analysis of the Behavioral Risk Factor Surveillance System.

Michael L Stellefson, Min Qi Wang, Isabelle M Boyd, Sarah M Flora, Olivia K Campbell, Karin F Hoth, Leah J Witt, Ashwin A Kotwal, Angela O Suen, Russell G Buhr and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of general internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Michael L StellefsonDepartment of Health Science, The University of Alabama, Tuscaloosa, AL, USA. stell001@ches.ua.edu.ORCID 0000-0003-1717-4114
Min Qi WangDepartment of Behavioral and Community Health, School of Public Health, University of Maryland, College Park, MD, USA.
Isabelle M BoydDepartment of Health Science, The University of Alabama, Tuscaloosa, AL, USA.
Sarah M FloraDepartment of Health Science, The University of Alabama, Tuscaloosa, AL, USA.
Olivia K CampbellDepartment of Health Science, The University of Alabama, Tuscaloosa, AL, USA.
Karin F HothDepartment of Psychiatry and Iowa Neuroscience Institute, University of Iowa, Iowa City, IA, USA.
Leah J WittDivision of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California San Francisco, San Francisco, CA, USA.
Ashwin A KotwalDivision of Geriatrics, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
Angela O SuenDivision of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California San Francisco, San Francisco, CA, USA.
Russell G BuhrDivision of Pulmonary and Critical Care Medicine, Department of Health Policy and Management, University of California, Los Angeles, CA, USA.
Anand S IyerDivision of Pulmonary, Allergy, and Critical Care Medicine and School of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA.

Funding

RESEARCH TRAINING IN GERIATRIC MEDICINET32AG000212 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Alexander Keliimoeanu Smith · 1991 to 2026
$7.7M
Aging Well with COPD through Geriatrics-Palliative CareK76AG064327 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI IYER, ANAND SATHYAN · 2020 to 2024
$1.2M
NHLBI NIH HHS L30 HL134025NIA NIH HHS K76 AG064327NIA NIH HHS T32 AG000212
6 · The paper itself

Abstract

backgroundSubjective cognitive decline (SCD), an early indicator of cognitive impairment, may affect COPD care and outcomes, yet its sociodemographic associations in Chronic Obstructive Pulmonary Disease (COPD) remain poorly understood.

objectiveTo investigate the prevalence of SCD among people with COPD across different age groups and identify associations between demographics, risk behaviors, comorbidities, and self-reported SCD.

designPooled 2019 BRFSS data from 24 states using the Cognitive Decline module were analyzed. Logistic regression assessed relationships between demographics, behaviors, comorbidities, and SCD, adjusting for confounders.

participantsA total of 12,003 adults with COPD aged ≥ 45 were included in the study (weighted population = 617,792). MAIN MEASURES: Prevalence of SCD, associations with demographics, behaviors, health status, income, employment, and smoking. KEY

resultsAmong adults with COPD, 24.1% reported SCD. The prevalence among those with SCD was highest in those aged 55-64 (30.2%), followed by 65-74 (24.5%) and 45-54 (23.1%). Older age (55 to 64: AOR = 0.63, 95% CI: 0.49 - 0.80; 65 to 74: AOR = 0.54, 95% CI: 0.40 - 0.72; 75 to 79: AOR = 0.41, 95% CI: 0.29 - 0.60; 80 + : AOR = 0.47, 95% CI: 0.32 - 0.69) and higher annual income (e.g., $25,000 to $49,999: AOR = 0.80, 95% CI: 0.65 - 0.99; $50,000 to $74,999: AOR = 0.68, 95% CI: 0.51 - 0.91) were associated with lower odds of reporting SCD, while unemployment (AOR = 1.73, 95% CI: 1.33 - 2.27), history of stroke (AOR = 1.35, 95% CI: 1.05 - 1.74), and fair or poor health (AOR = 0.47, 95% CI: 0.39 - 0.57) were linked to higher odds of reporting SCD.

conclusionsAmong adults with COPD, the prevalence of SCD varied by age, with the highest rates in those aged 55-64, and was independently associated with socioeconomic factors and health risks, emphasizing the complex interplay of demographic and health-related factors in SCD.

Indexed as

Behavioral Risk Factor Surveillance SystemCognitive DysfunctionPulmonary Disease, Chronic ObstructiveAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrevalenceUnited StatesCOPDSociodemographic risksSubjective cognitive decline

Identifiers

PMID40064819
PMCPMC12508341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.